166 related articles for article (PubMed ID: 24859332)
1. GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia.
Yuki N; Fukami Y; Yanaka C; Koike S; Hirata K
J Neurol; 2014 Aug; 261(8):1565-9. PubMed ID: 24859332
[TBL] [Abstract][Full Text] [Related]
2. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
3. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
4. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
6. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
Koga M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
[TBL] [Abstract][Full Text] [Related]
7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
8. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
9. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
10. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes.
Shahrizaila N; Kokubun N; Sawai S; Umapathi T; Chan YC; Kuwabara S; Hirata K; Yuki N
Neurology; 2014 Jul; 83(2):118-24. PubMed ID: 24920848
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
13. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.
Koga M; Gilbert M; Takahashi M; Li J; Hirata K; Kanda T; Yuki N
J Neurol; 2012 Jul; 259(7):1366-74. PubMed ID: 22218648
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
15. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides.
Willison HJ; Almemar A; Veitch J; Thrush D
Neurology; 1994 Dec; 44(12):2395-7. PubMed ID: 7991134
[TBL] [Abstract][Full Text] [Related]
16. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
18. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery.
Notturno F; Caporale CM; Uncini A
Muscle Nerve; 2008 Feb; 37(2):265-8. PubMed ID: 17823951
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
